The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses
Grace R, Neufeld E, Ritchey A, Kumar M, Jeng M, Blanchette V, Klaassen R, Buchanan G, Kurth M, Nugent D, Thompson A, Thornburg C, Lambert M, Neier M, Recht M, Stine K, Kalish L, Bennett C. The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses. Blood 2010, 116: 2509. DOI: 10.1182/blood.v116.21.2509.2509.Peer-Reviewed Original ResearchChronic immune thrombocytopeniaDirect anti-globulin testAcute immune thrombocytopeniaImmune thrombocytopeniaSecondary immune thrombocytopeniaEvans syndromeITP diagnosisAnti-DPlatelet countClinical diagnosis of immune thrombocytopeniasMedian duration of follow-upDiagnosis of immune thrombocytopeniaPediatric chronic immune thrombocytopeniaShort course of steroidsPredictors of response to treatmentAged 6 months-18 yearsDuration of follow-upPositive direct anti-globulin testImmune Thrombocytopenia diagnosisPlatelet count responseResponse to IVIGResponse to splenectomyCourse of steroidsPrimary immune thrombocytopeniaMedian platelet countResponse to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.
Grace R, Bennett C, Ritchey A, Jeng M, Thornburg C, Lambert M, Neier M, Recht M, Kumar M, Blanchette V, Klaassen R, Buchanan G, Kurth M, Nugent D, Thompson A, Stine K, Kalish L, Neufeld E. Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia. Blood 2010, 116: 3681. DOI: 10.1182/blood.v116.21.3681.3681.Peer-Reviewed Original ResearchPredictor of response to rituximabResponse to rituximabSecondary immune thrombocytopeniaResponse to steroidsChronic immune thrombocytopeniaDiagnosis of immune thrombocytopeniaImmune thrombocytopeniaEvans syndromeITP diagnosisUnivariate predictorsTreatment responseClinical diagnosis of immune thrombocytopeniasPediatric chronic immune thrombocytopeniaPredicting response to rituximabPatients treated with rituximabRefractory to other therapiesResponse to prior treatmentAged 6 months-18 yearsPredictors of therapy responseAcute immune thrombocytopeniaImmune Thrombocytopenia diagnosisWeeks of rituximabTreated with rituximabMedian platelet countPediatric immune thrombocytopenia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply